Curaleaf Holdings Inc

Curaleaf’s bold restructuring—bundling a special meeting with its AGM—aims to keep its Canadian roots while gaining Delaware’s legal flexibility, a move that could reshape investor sentiment and the company’s future in a volatile cannabis market.

Curaleaf launches adult‑use sales in Maine, boosting market reach despite a negative P/E and volatile stock, showing investor optimism amid cannabis industry growth.

Curaleaf Holdings Inc. set to release 2025 earnings, promising insights on growth, margins, and cash flow amid Canada’s stable policy outlook and cannabis‑sector optimism.

Curaleaf Holdings’ latest market moves reveal how it’s tackling cannabis industry volatility—leveraging a broad dispensary network, supply‑chain upgrades, and innovation to boost growth.

Curaleaf Holdings, a leading US cannabis distributor, has secured a $100 million revolving credit facility from Needham Bank, providing the company with increased liquidity and flexibility to support expansion, acquisitions, and capital expenditures.

Curaleaf Holdings Inc. saw its stock price surge by over 15% on August 4, 2025, driven by positive industry developments and research from the American Medical Association.

Curaleaf Holdings has expanded its presence in Florida with the opening of a new medical cannabis dispensary in St. Augustine, marking its 68th store in the state.

Curaleaf Holdings Inc has made a strategic power play in the cannabis sector by acquiring its minority partner, solidifying its position as a dominant player in the global market.

Curaleaf Holdings Inc. expands its reach with a new dispensary in Ohio and launches its branded medical cannabis products in Australia, marking a significant step in its global strategy to tap into emerging markets.